Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone

Steroids

Volumn 71, Issue 10, 2006, Pages 880-885

  Falany, Josie L ^a   Falany, Charles N ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Endometrium; Induction; Progesterone; Sulfation; Sulfotransferase; Tibolone

Indexed keywords

ANDROGEN RECEPTOR; MIFEPRISTONE; PROGESTERONE; SULFOTRANSFERASE; SULFOTRANSFERASE 1E1; TIBOLONE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG METABOLISM; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SULFATION;

CELL LINE, TUMOR; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NORPREGNENES; SULFOTRANSFERASES;

EID: 33748585937     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.05.018     Document Type: Article

References (27)

1. Kloosterboer H.J. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76 (2001) 231-238
2. Kenemans P., and Speroff L. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 51 (2005) 21-28
3. Steckelbroeck S., Jin Y., Oyesanmi B., Kloosterboer H.J., and Penning T.M. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. Mol Pharmacol 66 (2004) 1702-1711
4. Vos R.M., Krebbers S.F., Verhoeven C.H., and Delbressine L.P. The in vivo human metabolism of tibolone. Drug Metab Dispos 30 (2002) 106-112
5. Timmer C.J., Verheul H.A., and Doorstam D.P. Pharmacokinetics of tibolone in early and late postmenopausal women. Br J Clin Pharmacol 54 (2002) 101-106
6. Tang B., Markiewicz L., Kloosterboer H.J., and Gurpide E. Human endometrial 3beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14). J Steroid Biochem Mol Biol 45 (1993) 345-351
7. de Gooyer M.E., Deckers G.H., Schoonen W.G., Verheul H.A., and Kloosterboer H.J. Receptor profiling and endocrine interactions of tibolone. Steroids 68 (2003) 21-30
8. Kloosterboer H.J., and Ederveen A.G. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments. J Steroid Biochem Mol Biol 83 (2002) 157-165
9. Blok L.J., De Ruiter P.E., Kuhne E.C., Hanekamp E.E., Grootegoed J.A., Smid-Koopman E., et al. Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab 88 (2003) 2327-2334
10. Schatz F., Kuczynski E., Kloosterboer H.J., Buchwalder L., Tang C., Krikun G., et al. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: evidence of progestogenic effects. Steroids 70 (2005) 840-845
11. Volker W., Coelingh Bennink H.J., and Helmond F.A. Effects of tibolone on the endometrium. Climacteric 4 (2001) 203-208
12. Verhoeven C.H., Vos R.M., and Delbressine L.P. The in vivo metabolism of tibolone in animal species. Eur J Drug Metab Pharmacokinet 27 (2002) 1-10
13. Falany J.L., Macrina N., and Falany C.N. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 88 (2004) 383-391
14. Kotov A., Falany J.L., Wang J., and Falany C.N. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 68 (1999) 137-144
15. Falany J.L., Azziz R., and Falany C.N. Identification and characterization of cytosolic sulfotransferases in normal human endometrium. Chem Biol Interact 109 (1998) 329-339
16. Falany J.L., and Falany C.N. Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone. Endocrinology 137 (1996) 1395-1401
17. Rubin G.L., Harrold A.J., Mills J.A., Falany C.N., and Coughtrie M.W. Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Mol Hum Reprod 5 (1999) 995-1002
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
19. Falany C.N., Vazquez M.E., and Kalb J.M. Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem J 260 (1989) 641-646
20. Markiewicz L., and Gurpide E. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. J Steroid Biochem 35 (1990) 535-541
21. Holinka C.F., Hata H., Kuramoto H., and Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem 24 (1986) 85-89
22. Holinka C.F., Hata H., Kuramoto H., and Gurpide E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res 46 (1986) 2771-2774
23. Zhang W, Mazella J, Kloosterboer HJ, Tseng L. Effects of tibolone on nuclear receptors in human endometrial cells. Am J Obstet Gynecol; 2006 [e-pub].
24. Hanifi-Moghaddam P., Gielen S.C., Kloosterboer H.J., De Gooyer M.E., Sijbers A.M., van Gool A.J., et al. Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone. J Clin Endocrinol Metab 90 (2005) 973-983
25. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., and Penning T.M. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem 279 (2004) 10784-10795
26. Tax L., Goorissen E.M., and Kicovic P.M. Clinical profile of Org OD 14. Maturitas Suppl 1 (1987) 3-13
27. Kloosterboer H.J. Tissue-selectivity: the mechanism of action of tibolone. Maturitas 48 Suppl 1 (2004) S30-S40